ACUTA CAPITAL PARTNERS LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:32 pm Sale |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 0 0.000% |
-391,209 (Position Closed) |
Filing |
| 2022-02-15 2:51 pm Sale |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 391,209 5.900% |
-24,290 (-5.85%) |
Filing |
| 2021-03-22 06:06 am Purchase |
2021-03-12 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 415,499 8.400% |
165,499 (+66.20%) |
Filing |
| 2021-02-16 06:14 am Purchase |
2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 250,000 5.400% |
250,000 (New Position) |
Filing |